Reprint of: Nonclinical species sensitivity to convulsions: An IQ DruSafe consortium working group initiative

Journal of Pharmacological and Toxicological Methods - Tập 105 - Trang 106919 - 2020
Jamie K. DaSilva1, Laura Breidenbach2, Tracy Deats3, Dingzhou Li1, Kimberly Treinen3, Theo Dinklo4, Sophie Kervyn5, Greet Teuns6, Martin Traebert7, Katja Hempel8
1Pfizer Drug Safety R&D, Pfizer, Inc, Groton, CT, USA
2AbbVie Deutschland GmbH & Co. KG, Preclinical Safety, Ludwigshafen, Knollstr 67061, Germany
3Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
4Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Basel, Switzerland
5UCB Biopharma Sprl, Development Science, Braine-l'Alleud, Belgium
6Global Safety Pharmacology, NonClinical Safety, Janssen R&D, Beerse, Belgium
7Novartis Institutes of Biomedical Research, Novartis Pharma AG, PO Box, Basel CH-4002, Switzerland
8Boehringer Ingelheim Pharma GmbH & Co. KG, Development NCE NDS, Biberach an der Riß 88397, Germany

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Journal of Pharmacological and Toxicological Methods

Tập 105

106919

Thông tin tác giả